9 research outputs found
Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications
The spread of artemisinin-resistant parasites could lead to
higher incidence of patients with malaria complications.
However, there are no current treatments that directly dislodge
sequestered parasites from the microvasculature. We show that
four common antiplasmodial drugs do not disperse rosettes
(erythrocyte clusters formed by malaria parasites) and therefore
develop a cell-based high-throughput assay to identify potential
rosette-disrupting compounds. A pilot screen of 2693 compounds
identified Malaria Box compound MMV006764 as a potential
candidate. Although it reduced rosetting by a modest 20%,
MMV006764 was validated to be similarly effective against both
blood group O and A rosettes of three laboratory parasite lines.
Coupled with its antiplasmodial activity and drug-likeness,
MMV006764 represents the first small-molecule compound that
disrupts rosetting and could potentially be used in a
resource-limited setting to treat patients deteriorating rapidly
from malaria complications. Such dual-action drugs that
simultaneously restore microcirculation and reduce parasite load
could significantly reduce malaria morbidity and mortality
INVESTIGATIONS INTO THE MECHANISMS OF PROGRAMMED CELL DEATH IN THE MALARIA PARASITE PLASMODIUM FALCIPARUM
Ph.DDOCTOR OF PHILOSOPH
Measuring rosetting inhibition in <i>Plasmodium falciparum</i> parasites using a flow cytometry-based assay
Enhanced virulence of Plasmodium falciparum in blood of diabetic patients
10.1371/journal.pone.0249666PLoS ONE166-June024966
SURGE complex of Plasmodium falciparum in the rhoptry-neck (SURFIN4.2-RON4-GLURP) contributes to merozoite invasion.
Plasmodium falciparum invasion into red blood cells (RBCs) is a complex process engaging proteins on the merozoite surface and those contained and sequentially released from the apical organelles (micronemes and rhoptries). Fundamental to invasion is the formation of a moving junction (MJ), a region of close apposition of the merozoite and the RBC plasma membranes, through which the merozoite draws itself before settling into a newly formed parasitophorous vacuole (PV). SURFIN4.2 was identified at the surface of the parasitized RBCs (pRBCs) but was also found apically associated with the merozoite. Using antibodies against the N-terminus of the protein we show the presence of SURFIN4.2 in the neck of the rhoptries, its secretion into the PV and shedding into the culture supernatant upon schizont rupture. Using immunoprecipitation followed by mass spectrometry we describe here a novel protein complex we have named SURGE where SURFIN4.2 forms interacts with the rhoptry neck protein 4 (RON4) and the Glutamate Rich Protein (GLURP). The N-terminal cysteine-rich-domain (CRD) of SURFIN4.2 mediates binding to the RBC membrane and its interaction with RON4 suggests its involvement in the contact between the merozoite apex and the RBC at the MJ. Supporting this suggestion, we also found that polyclonal antibodies to the extracellular domain (including the CRD) of SURFIN4.2 partially inhibit merozoite invasion. We propose that the formation of the SURGE complex participates in the establishment of parasite infection within the PV and the RBCs
Heme cross-feeding can augment Staphylococcus aureus and Enterococcus faecalis dual species biofilms
The contribution of biofilms to virulence and as a barrier to treatment is well-established for Staphylococcus aureus and Enterococcus faecalis, both nosocomial pathogens frequently isolated from biofilm-associated infections. Despite frequent co-isolation, their interactions in biofilms have not been well-characterized. We report that in combination, these two species can give rise to augmented biofilms biomass that is dependent on the activation of E. faecalis aerobic respiration. In E. faecalis, respiration requires both exogenous heme to activate the cydAB-encoded heme-dependent cytochrome bd, and the availability of O2. We determined that the ABC transporter encoded by cydDC contributes to heme import. In dual species biofilms, S. aureus provides the heme to activate E. faecalis respiration. S. aureus mutants deficient in heme biosynthesis were unable to augment biofilms whereas heme alone is sufficient to augment E. faecalis mono-species biofilms. Our results demonstrate that S. aureus-derived heme, likely in the form of released hemoproteins, promotes E. faecalis biofilm formation, and that E. faecalis gelatinase activity facilitates heme extraction from hemoproteins. This interspecies interaction and metabolic cross-feeding may explain the frequent co-occurrence of these microbes in biofilm-associated infections.Published versio
Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications
The spread of artemisinin-resistant parasites could lead to
higher incidence of patients with malaria complications.
However, there are no current treatments that directly dislodge
sequestered parasites from the microvasculature. We show that
four common antiplasmodial drugs do not disperse rosettes
(erythrocyte clusters formed by malaria parasites) and therefore
develop a cell-based high-throughput assay to identify potential
rosette-disrupting compounds. A pilot screen of 2693 compounds
identified Malaria Box compound MMV006764 as a potential
candidate. Although it reduced rosetting by a modest 20%,
MMV006764 was validated to be similarly effective against both
blood group O and A rosettes of three laboratory parasite lines.
Coupled with its antiplasmodial activity and drug-likeness,
MMV006764 represents the first small-molecule compound that
disrupts rosetting and could potentially be used in a
resource-limited setting to treat patients deteriorating rapidly
from malaria complications. Such dual-action drugs that
simultaneously restore microcirculation and reduce parasite load
could significantly reduce malaria morbidity and mortality
A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-Dichlorobenzamil on the digestive vacuole of plasmodium falciparum
Plasmodium falciparum is the etiological agent of malignant malaria and has been shown to exhibit features resembling programmed cell death. This is triggered upon treatment with low micromolar doses of chloroquine or other lysosomotrophic compounds and is associated with leakage of the digestive vacuole contents. In order to exploit this cell death pathway, we developed a high-content screening method to select compounds that can disrupt the parasite vacuole, as measured by the leakage of intravacuolar Ca2+. This assay uses the ImageStream 100, an imaging-capable flow cytometer, to assess the distribution of the fluorescent calcium probe Fluo-4. We obtained two hits from a small library of 25 test compounds, quinacrine and 3',4'-dichlorobenzamil. The ability of these compounds to permeabilize the digestive vacuole in laboratory strains and clinical isolates was validated by confocal microscopy. The hits could induce programmed cell death features in both chloroquine-sensitive and -resistant laboratory strains. Quinacrine was effective at inhibiting field isolates in a 48-h reinvasion assay regardless of artemisinin clearance status. We therefore present as proof of concept a phenotypic screening method with the potential to provide mechanistic insights to the activity of antimalarial drugs. © 2014, American Society for Microbiology